Stock CHRO CHROMOCELL THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Chromocell Therapeutics Corporation

Equities

CHRO

US1711261057

Delayed Nyse
Other stock markets
 13:14:43 2024-06-07 EDT 		5-day change 1st Jan Change
1.42 USD -4.05% Intraday chart for Chromocell Therapeutics Corporation +5.97% 0.00%
05-15 Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-16 Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program
CI
Chromocell Therapeutics Corporation has completed an IPO in the amount of $6.6 million.
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CHRO Stock
  4. News Chromocell Therapeutics Corporation
  5. Highlights